Summary of Purpose
The research focuses on the safety profile of androgen-deprivation therapy (ADT). The hypothesis is that safety issue, as regards to cardiovascular risk, is not homogenous across the spectrum of androgen-deprivation therapy modalities. Our study will encompass all ADT modalities including intermittent ADT. ADT is a cornerstone therapy in prostate cancer management. Decisions about ADT should weigh ...Read More →
The following dates are available for this trial. Trial information last updated on 10 April 2017.
|1 Apr 2015||6 Sep 2016||1 Dec 2017||1 Dec 2017||1 Apr 2017||Unavailable|
|Start Date||First Received||1st Completion||Completion||Verification||Results|
- Observation: Cohort
- Perspective: Prospective
- Sampling: Non-Probability Sample